text
stringlengths 0
146
|
|---|
• Non-invasive;
|
• Carcinoma-in-situ (Tis)
|
or Ta;
|
• Having borderline
|
malignancy;
|
• Having any degree of
|
malignant potential;
|
• Having suspicious
|
malignancy;
|
• Neoplasm of uncertain
|
or unknown behavior; or
|
• All grades of dysplasia,
|
squamous intraepithelial
|
lesions (HSIL and LSIL)
|
and intra epithelial
|
neoplasia;
|
B) Any non-melanoma
|
skin carcinoma, skin
|
confined primary
|
cutaneous lymphoma and
|
dermatofibrosarcoma
|
protuberans unless there
|
is evidence of metastases
|
to lymph nodes or beyond;
|
C) Malignant melanoma
|
that has not caused
|
invasion beyond the
|
epidermis;
|
D) All Prostate cancers
|
histologically described as
|
T1N0M0 (TNM
|
Classification) or below; or
|
Prostate cancers of
|
another equivalent or
|
lesser classification;
|
E) All Thyroid cancers
|
histologically classified as
|
T1N0M0 (TNM
|
Classification) or below;
|
F) All Neuroendocrine
|
tumours histologically
|
classified as T1N0M0
|
(TNM Classification) or
|
below;
|
G) All tumours of the
|
Urinary Bladder
|
histologically classified as
|
T1N0M0 (TNM
|
Classification) or below;
|
H) All Gastro-Intestinal
|
Stromal tumours
|
histologically classified as
|
Stage I or IA according to
|
the latest edition of the
|
AJCC Cancer Staging
|
Manual, or below;
|
I) Chronic Lymphocytic
|
Leukaemia less than RAI
|
Stage 3;
|
Manulife CI FlexiCare (Deluxe) v0123
|
Page 23 of 42
|
Manulife (Singapore) Pte. Ltd.
|
A Manulife Company
|
Conditions
|
Early Stage
|
transplant or other major
|
interventionist treatment.
|
The diagnosis of the
|
above minor cancers must
|
be established by
|
histological evidence and
|
be confirmed by a
|
specialist in the relevant
|
field.
|
The following conditions
|
are specifically excluded
|
from coverage:
|
• Clinical diagnosis
|
• Any diagnosis on the
|
basis of finding tumour
|
cells and/or tumorassociated molecules in
|
blood, saliva, faeces,
|
urine or any other bodily
|
fluid in the absence of
|
further definitive and
|
clinically verifiable
|
evidence does not meet
|
the above definition.
|
• Any lesion or tumour
|
which is histologically
|
described as benign,
|
dysplasia, premalignant,
|
borderline malignant, or
|
suspicious malignant
|
potential.
|
• Cervical Dysplasia, CIN1, CIN-2 and CIN-3 and
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.